|Other Names||Endoplasmic reticulum-Golgi intermediate compartment protein 3, Serologically defined breast cancer antigen NY-BR-84, ERGIC3, C20orf47, ERV46, SDBCAG84|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP9217a was selected from the N-term region of human ERGIC3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Synonyms||C20orf47, ERV46, SDBCAG84|
|Function||Possible role in transport between endoplasmic reticulum and Golgi.|
|Cellular Location||Endoplasmic reticulum-Golgi intermediate compartment membrane; Multi-pass membrane protein. Golgi apparatus, cis-Golgi network membrane; Multi- pass membrane protein. Endoplasmic reticulum membrane; Multi-pass membrane protein. Note=Cycles between the endoplasmic reticulum and the Golgi|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
ERGIC3 is possible role in transport between endoplasmic reticulum and Golgi.
Nishikawa,M., et.al., Gene 386 (1-2), 42-51 (2007)Breuza,L., et.al., J. Biol. Chem. 279 (45), 47242-47253 (2004)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.